approval · primary record
MEROPENEM
3 approval events · latest 2026-08-10
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-08-10 |
| Approval events | 3 |
| Brand | MEROPENEM |
| Sponsor | HQ SPCLT PHARMA |
| Route | INTRAVENOUS |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-08-10 | FDA | NDA | MEROPENEM | HQ SPCLT PHARMA | INTRAVENOUS |
| 2025-05-02 | FDA | NDA | MERREM IV | PFIZER | INJECTION |
| 2024-12-03 | FDA | NDA | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | B BRAUN MEDICAL | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:27:50.751Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:meropenem
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Meropenem · compound